165 related articles for article (PubMed ID: 5146413)
1. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Chase RN; Schnur JA; Brody JA; Gordon EK
Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
[No Abstract] [Full Text] [Related]
2. Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of Guam.
Brody JA; Chase TN; Gordon EK
N Engl J Med; 1970 Apr; 282(17):947-50. PubMed ID: 5436031
[No Abstract] [Full Text] [Related]
3. Amyotrophic lateral sclerosis. A study of central monoamine metabolism and therapeutic trial of levodopa.
Mendell JR; Chase TN; Engel WK
Arch Neurol; 1971 Oct; 25(4):320-5. PubMed ID: 5110126
[No Abstract] [Full Text] [Related]
4. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
Bowers MB
Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
[No Abstract] [Full Text] [Related]
5. Parkinsonism-dementia of Guam: treatment with L-dopa.
Schnur JA; Chase TN; Brody JA
Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247
[No Abstract] [Full Text] [Related]
6. Central monoamine metabolism in Parkinson's disease.
Chase TN; Ng LK
Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
[No Abstract] [Full Text] [Related]
7. Amyotrophic lateral sclerosis: metabolism of central monoamines and treatment with L-dopa.
Mendell JR; Chase TN; Engel WK
Trans Am Neurol Assoc; 1971; 96():284-6. PubMed ID: 5159109
[No Abstract] [Full Text] [Related]
8. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
Rinne UK; Sonninen V
Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
[No Abstract] [Full Text] [Related]
9. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
[No Abstract] [Full Text] [Related]
10. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
Johansson B; Roos BE
Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
[No Abstract] [Full Text] [Related]
11. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
Gottfires CG; Roos BE
Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
[No Abstract] [Full Text] [Related]
12. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
Vanderheyden JE; Noel G; Mendlewicz J
Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
[TBL] [Abstract][Full Text] [Related]
13. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
Mendlewicz J; Vanderheyden JE; Noel G
Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
[TBL] [Abstract][Full Text] [Related]
14. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
Garelis E; Young SN; Lal S; Sourkes TL
Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
[No Abstract] [Full Text] [Related]
15. Amine metabolism in the human brain: further evaluation of the probenecid test.
Korf J; Van Praag HM
Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
[No Abstract] [Full Text] [Related]
16. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
Olsson R; Roos BE
Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
[No Abstract] [Full Text] [Related]
17. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
18. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
19. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
[No Abstract] [Full Text] [Related]
20. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
van Woert MH; Bowers MB
Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
